<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(5)</volume><submitter>Mao Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Subxiphoid approach for mediastinal tumor resection was reported to provide a better view and less postoperative pain. Non-intubated video-assisted thoracic surgery (NI-VATS) without muscle relaxant would decrease the possibility of postoperative airway collapse for anterior mediastinal mass operation. Herein, we sought to describe the use of NI-VATS through subxiphoid approach for anterior mediastinal tumor resection.&lt;h4>Methods&lt;/h4>In this retrospective cohort study, patients that underwent subxiphoid VATS resection for anterior mediastinal tumor between December 2015 and September 2019 were divided into two groups: NI-VATS and intubated VATS (I-VATS). Intraoperative and postoperative variables were compared.&lt;h4>Results&lt;/h4>A total of 40 patients were included. Among them, 21 patients received NI-VATS (52.5%) and 19 were treated with I-VATS (47.5%). In total, intraoperative (4/21 &lt;i>vs&lt;/i>. 2/19; P=0.446) and postoperative complications (5/21 &lt;i>vs&lt;/i>. 7/19; P=0.369) were similar between NI-VATS and I-VATS group. The anesthesia time (231.76 &lt;i>vs&lt;/i>. 244.71 min; P=0.218), the operation time (152.35 &lt;i>vs&lt;/i>. 143.64 min; P=0.980), chest tube duration (1.81 &lt;i>vs&lt;/i>. 1.84 days; P=0.08), the total volume (351.95 &lt;i>vs&lt;/i>. 348.00 mL; P=0.223), post-operative pain scores (2.79 &lt;i>vs&lt;/i>. 2.93, P=0.413), and the length of stay (9.47 &lt;i>vs&lt;/i>. 10.57 days; P=0.970) were all comparable between two groups.&lt;h4>Conclusions&lt;/h4>NI-VATS for mediastinal tumor resection via subxiphoid approach is a safe and technically feasible option in selected patients, which leads to comparable perioperative clinical outcomes when compared with I-VATS via the subxiphoid approach. This technique could be used as an alteration when intubation is not available.</pubmed_abstract><journal>Annals of translational medicine</journal><pagination>403</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8033331</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Non-intubated video-assisted thoracic surgery for subxiphoid anterior mediastinal tumor resection.</pubmed_title><pmcid>PMC8033331</pmcid><pubmed_authors>Qiu Y</pubmed_authors><pubmed_authors>Deng S</pubmed_authors><pubmed_authors>Jiang L</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>He J</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Mao Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-intubated video-assisted thoracic surgery for subxiphoid anterior mediastinal tumor resection.</name><description>&lt;h4>Background&lt;/h4>Subxiphoid approach for mediastinal tumor resection was reported to provide a better view and less postoperative pain. Non-intubated video-assisted thoracic surgery (NI-VATS) without muscle relaxant would decrease the possibility of postoperative airway collapse for anterior mediastinal mass operation. Herein, we sought to describe the use of NI-VATS through subxiphoid approach for anterior mediastinal tumor resection.&lt;h4>Methods&lt;/h4>In this retrospective cohort study, patients that underwent subxiphoid VATS resection for anterior mediastinal tumor between December 2015 and September 2019 were divided into two groups: NI-VATS and intubated VATS (I-VATS). Intraoperative and postoperative variables were compared.&lt;h4>Results&lt;/h4>A total of 40 patients were included. Among them, 21 patients received NI-VATS (52.5%) and 19 were treated with I-VATS (47.5%). In total, intraoperative (4/21 &lt;i>vs&lt;/i>. 2/19; P=0.446) and postoperative complications (5/21 &lt;i>vs&lt;/i>. 7/19; P=0.369) were similar between NI-VATS and I-VATS group. The anesthesia time (231.76 &lt;i>vs&lt;/i>. 244.71 min; P=0.218), the operation time (152.35 &lt;i>vs&lt;/i>. 143.64 min; P=0.980), chest tube duration (1.81 &lt;i>vs&lt;/i>. 1.84 days; P=0.08), the total volume (351.95 &lt;i>vs&lt;/i>. 348.00 mL; P=0.223), post-operative pain scores (2.79 &lt;i>vs&lt;/i>. 2.93, P=0.413), and the length of stay (9.47 &lt;i>vs&lt;/i>. 10.57 days; P=0.970) were all comparable between two groups.&lt;h4>Conclusions&lt;/h4>NI-VATS for mediastinal tumor resection via subxiphoid approach is a safe and technically feasible option in selected patients, which leads to comparable perioperative clinical outcomes when compared with I-VATS via the subxiphoid approach. This technique could be used as an alteration when intubation is not available.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-04T21:25:00.796Z</modification><creation>2025-04-04T21:25:00.796Z</creation></dates><accession>S-EPMC8033331</accession><cross_references><pubmed>33842624</pubmed><doi>10.21037/atm-20-6125</doi></cross_references></HashMap>